Lanean...
Neoadjuvant therapy for resectable pancreatic cancer
The use of neoadjuvant therapies has played a major role for borderline resectable and locally advanced pancreatic cancers (PCs). For this group of patients, preoperative chemotherapy or chemoradiation has increased the likelihood of surgery with negative resection margins and overall survival. On t...
Gorde:
| Argitaratua izan da: | World J Gastrointest Oncol |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Baishideng Publishing Group Inc
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5740086/ https://ncbi.nlm.nih.gov/pubmed/29290916 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v9.i12.457 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|